Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
4
8
1
0
Verve Therapeutics, Inc. - Common Stock Share · US92539P1012 · VERV (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Verve Therapeutics, Inc. - Common Stock
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 73,19 %
Shares Float 65,37 M
Shares Outstanding 89,31 M
Company Profile for Verve Therapeutics, Inc. - Common Stock Share
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Company Data
Name Verve Therapeutics, Inc. - Common Stock
Company Verve Therapeutics, Inc.
Symbol VERV
Website
https://www.vervetx.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US92539P1012
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Sekar Kathiresan
Market Capitalization 994 Mio
Country United States of America
Currency USD
Employees 0,3 T
Address 500 Technology Square, 02139 Boston
IPO Date 2021-06-17
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | VERV |
More Shares
Investors who hold Verve Therapeutics, Inc. - Common Stock also have the following shares in their portfolio:
